TrialBMC musculoskeletal disorders2011

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.

Boulos Haraoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.